single oral doses of 50 to 400 mg, fluconazole plasma concentrations and area under
200 mg
The daily dose of fluconazole for the treatment of infections other than vaginal candidiasis should be based on the infecting organism and the patient's response to therapy
HIV-infected adults who cannot receive amphotericin B: Induction therapy with oral or IV fluconazole 400–800 mg daily and oral flucytosine given for at least 4–6 weeks, then consolidation
Dose of 12 mg/kg once daily may be used, based on patient’s response
Clancy's data suggest that both fluconazole MIC and dose to MIC ratio correlate with the therapeutic response to fluconazole in patients with candidemia
65 mcg/mL] at 5
, the authors recommended to administer the usual dose of fluconazole in patients undergoing continuous renal replacement therapy, whatever the procedure used
05 mg/kg was administered intravenously on the fourth day, and 7
14 days except in severely immunocompromised patients); for 14–30 days in other mucosal infections (e
Fluconazole
Amphotericin B deoxycholate in combination with flucytosine for 1 week followed by fluconazole 1,200 mg once daily for 1 week (preferred regimen) (WHO 2018); or
400 mg IV/PO x1 now, then post-HD
Patients with esophageal candidiasis should be treated for a minimum of three weeks and for at least two weeks following The daily dose of fluconazole for the treatment of infections other than vaginal candidiasis should be based on the infecting organism and the patient’s response to therapy
Visit Pfizer Medical Information for more resources on Diflucan and other Pfizer products
In the study, subjects ingested placebo or 400 mg fluconazole on Day 1 followed by 200 mg daily from Day 2 to Day 6
Fluconazole reduced the clearance of IV
In addition, a 7
Current fluconazole dosing regimens do not achieve adequate early target attainment in critically ill adults, particularly in those who are overweight, have higher creatinine clearance, or are undergoing CRRT